10/11/2026
This brings so much hope for the future for treating those diagnosed with glioblastoma. ๐๐
When Tracey Kassman was diagnosed with glioblastoma in 2022 at age 64, she thought her life was over. But she decided to take a chance and joined a trial studying an experimental vaccine.
NBC News first spoke with Kassman in 2023. At the time, she didnโt know if she would be alive to see that original story published. โFour years later, Iโm still here,โ she said.
Drugmaker MimiVax announced results from the trial Kassman joined for SurVaxM, aimed at preventing the recurrence of glioblastoma. While the overall results were mixed, there were encouraging signs for people under 65 who got the vaccine.
If the FDA approves SurVaxM, it could mark a major milestone for the treatment of an aggressive brain cancer that has only a few major medical advances.
Subscribe to read this story: nbcnews.to/4dsZdDo